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Abstract 
A 10.5‐year‐old, male, neutered Samoyed was presented to the Iowa State University Lloyd Veterinary 
Medical Center with history (including prior surgical biopsy), non‐specific acute clinical signs and 
clinicopathology changes most consistent with pancreatitis. Marked hypercalcemia developed within a 
short span of time, raising clinical concerns for neoplasia. Diagnostic imaging and fine‐needle aspirate 
cytology were consistent with pancreatitis. Marked elevation in parathyroid hormone–related protein with 
low parathyroid hormone further supported the diagnosis of underlying neoplasia. The dog’s clinical 
status declined despite aggressive medical supportive therapy. Humane euthanasia was elected. 
Postmortem examination revealed an extensive pancreatic neoplasm confirmed as exocrine pancreatic 
adenocarcinoma with diffuse intra‐abdominal metastases. Acute kidney injury most likely resulted from 
the severe pancreatic inflammation (pancreatitis) and hypercalcemia of malignancy caused by the 
exocrine pancreatic adenocarcinoma. This is the first reported case of hypercalcemia of malignancy 
associated with exocrine pancreatic adenocarcinoma in a dog. 
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SUMMARY
A 10.5- year- old, male, neutered Samoyed was presented 
to the Iowa State University Lloyd Veterinary Medical 
Center with history (including prior surgical biopsy), 
non- speciic acute clinical signs and clinicopathology 
changes most consistent with pancreatitis. Marked 
hypercalcemia developed within a short span of time, 
raising clinical concerns for neoplasia. Diagnostic imaging 
and ine- needle aspirate cytology were consistent 
with pancreatitis. Marked elevation in parathyroid 
hormone–related protein with low parathyroid hormone 
further supported the diagnosis of underlying neoplasia. 
The dog’s clinical status declined despite aggressive 
medical supportive therapy. Humane euthanasia 
was elected. Postmortem examination revealed an 
extensive pancreatic neoplasm conirmed as exocrine 
pancreatic adenocarcinoma with diffuse intra- abdominal 
metastases. Acute kidney injury most likely resulted from 
the severe pancreatic inlammation (pancreatitis) and 
hypercalcemia of malignancy caused by the exocrine 
pancreatic adenocarcinoma. This is the irst reported case 
of hypercalcemia of malignancy associated with exocrine 
pancreatic adenocarcinoma in a dog.
BACKGROUND
Hypercalcemia of malignancy (HM) in dogs is 
most commonly associated with lymphoma or 
apocrine gland anal sac adenocarcinoma (AGASAC) 
and usually results from production of parathy-
roid hormone–related protein (PTHrP) by the 
neoplastic cells.1 2 A number of other carcinomas 
(squamous cell, thyroid, mammary, pulmonary, etc) 
have also been less commonly identified as causes 
of HM.2 3 This report highlights the first case of 
exocrine pancreatic adenocarcinoma resulting 
in HM in a dog. Hypercalcemia of malignancy 
resulting from increased production of PTHrP is 
reported in human exocrine pancreatic adenocar-
cinoma, particularly in those cases with adenos-
quamous differentiation.4 This case also highlights 
the key clinical point that pancreatic adenocar-
cinoma can mimic pancreatitis on the basis of 
presentation, physical examination findings, and 
clinicopathology and diagnostic imaging results. 
These similarities are likely related to the intense 
pancreatic inflammation occurring secondary to 
the neoplastic process.5 6 Although rarely reported 
in dogs, exocrine pancreatic adenocarcinoma 
should be considered as a differential diagnosis 
in cases of suspected pancreatitis not responsive 
to typical supportive therapies or in cases with 
hypercalcemia and pertinent pancreatic clinical 
signs and/or changes on clinicopathology or diag-
nostic imaging.
CASE PRESENTATION
A 10.5- year- old, male, neutered Samoyed was 
presented to the Iowa State University Lloyd Veter-
inary Medical Center for evaluation of progressive, 
intermittent vomiting, hyporexia and lethargy. On 
initial physical examination, the dog was quiet, alert 
and responsive with a body weight of 24.3 kg and 
body condition score of 5/9. Additional findings 
were elevated body temperature (39.8°C); heart 
rate 108 beats/min with regular rhythm and strong, 
synchronous femoral pulses; respiratory rate 36 
breaths/min, eupneic with clear lung fields; and 
mucous membranes pink and slightly tacky. Clinical 
dehydration status was estimated at <5 per cent. 
The dog’s abdomen was mildly distended, tense 
and painful on palpation with no organomegaly 
or distinct masses palpable. Urine dribbling was 
noted. Peripheral lymph nodes were small, soft and 
symmetrical. Rectal examination was unremark-
able with no masses or lymphadenomegaly. Fundic 
examination was unremarkable.
Evaluation by the primary care veterinarian 3 
days earlier had revealed elevated body tempera-
ture (39.4°C) with a slightly distended and tense 
abdomen. Diagnostics performed at that time 
showed neutrophilia (15.0×103/µL, reference 
interval (RI) 2.95–11.64) and mildly elevated canine 
pancreatic lipase immunoreactivity (cPLI, 235 µg/L, RI ≤200). Baseline cortisol (1.6 µg/dL, RI 1.0–5.0) 
and total calcium (9.1 mg/dL, RI 7.9–12.0) were 
within reference interval. Diagnostic imaging had 
no significant findings in two- view thoracic radio-
graphs; however, abdominal radiographs had loss 
of serosal detail with a mottled appearance in the 
cranioventral abdomen.
Previous history included exploratory 
coeliotomy for duodenal foreign body removal 
at 2 years of age, during which gross changes 
were observed in the pancreas, a biopsy taken, 
Figure 1 Diffusely enlarged left (A) and right 
(B) pancreatic lobes exhibit hypoechoic, mildly 
heterogeneous parenchyma with undulant margins and 
surrounding hyperechoic mesenteric fat.
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and histopathology- confirmed necrosuppurative pancreatitis. 
Subsequent clinical episodes consistent with pancreatitis were 
managed with supportive medical therapy (antiemetics) and diet. 
One year prior to presentation for the current condition, spon-
taneous pneumothorax was diagnosed. A right middle lung lobe 
lobectomy was performed with no concerning changes noted on 
histopathology. No further respiratory clinical signs had been 
observed.
INVESTIGATIONSComplete blood count (CBC) at presentation revealed leucocy-
tosis (29.52/µL, RI 6.0–17.0) composed of a neutrophilia (26.86/
µL, RI 3.0–11.4) and mild left shift (886 band neutrophils/µL, 
RI 0–300) with slight toxic granulation; and mild normocytic, 
normochromic anaemia (haematocrit 29.6 per cent, RI 37–55). 
Serum biochemistry profile indicated increased total calcium 
(13.4 mg/dL, RI 9.7–11.3). Ionised calcium was elevated (1.71 
mmol/L, RI 1.25–1.45). Urinalysis showed isosthenuria (urine 
specific gravity 1.009) with 1+ protein; urine protein:creatinine 
ratio was 1.99. Canine trypsin- like immunoreactivity (cTLI) was 
elevated (>50 µg/L, RI 5.7–45.2), as was cPLI (272 µg/L, RI 
<200 ug/L); serum folate and cobalamin were within reference 
interval. ACTH stimulation test indicated elevated pre- cortisol 
level (8.84 µg/dL, RI 1.0–5.0) with post- cortisol within refer-
ence interval (18.5 µg/dL, RI 5.5–20.0).
Thoracic radiographs (three- view) revealed moderate sternal 
lymphadenomegaly suspected to be secondary to abdominal 
disease; no visible changes consistent with metastatic neoplasia 
were observed. The entire pancreas was markedly enlarged and 
hypoechoic on abdominal ultrasound, extending caudally near 
the level of the urinary bladder (figure 1). The surrounding 
adipose was heterogeneous and hyperechoic; a moderate 
amount of hypoechoic free abdominal fluid was present. An 
enlarged, lobular pancreatic lymph node was noted near the 
left limb of the pancreas. Several small, hyperechoic nodules 
were noted within the spleen near the mesenteric margin. Due 
to changes observed on ultrasound, fine- needle aspirates were 
obtained from the pancreas and spleen; a sample of free peri-
toneal fluid was obtained for analysis. Although no changes 
were noted on ultrasound evaluation of the liver, fine- needle 
aspirates were performed to exclude lymphoma as a cause of 
HM. The enlarged pancreatic lymph node was not accessible 
for aspiration. Pancreatic cytology revealed neutrophilic inflam-
mation with pyogranulomatous steatitis, necrosis, and typical 
and low numbers of atypical (high nuclear to cytoplasmic ratio) 
pancreatic cells. Differentials for the atypical pancreatic cells 
were morphology changes due to inflammation and necrosis or 
possible neoplasia. Splenic cytology indicated mild hemosiderin 
and extramedullary hematopoiesis. Liver cytology indicated 
mild bile retention and blood- associated neutrophilia. Perito-
neal fluid analysis was consistent with a neutrophilic inflam-
matory exudate. Sternal bone marrow aspirate was performed 
and no evidence of lymphoma or other neoplasia was identi-
fied. A hypercalcemia panel was submitted to the Michigan State 
University Veterinary Diagnostic Laboratory.
DIFFERENTIAL DIAGNOSISBased on the clinical history and presentation, diagnostic imaging, inflammatory changes noted on CBC and aspirates of 
the pancreas and abdominal fluid, pancreatitis was the initial 
primary differential diagnosis. However, the newly identified 
hypercalcemia was not expected with acute pancreatitis as this 
condition is most commonly associated with hypocalcemia.7 
Given the extensive pancreatic changes noted on abdominal 
ultrasound along with hypercalcemia, further consideration 
was given to pancreatic neoplasia (lymphoma, adenocarci-
noma, insulinoma). The dog was normoglycemic and cytology 
of the pancreas and abdominal fluid revealed no indication of 
lymphoma, so the most likely diagnosis became exocrine pancre-
atic adenocarcinoma.
TREATMENT
Intravenous fluid diuresis with 0.9 per cent sodium chloride was 
initiated at 100 mL/kg/day. Fentanyl was administered intrave-
nously at 3 to 5 µg/kg/h as indicated for abdominal pain relief 
(response monitored via Colorado State University Canine Acute 
Pain Scale).8 Supportive medical therapy included pantoprazole 
1 mg/kg intravenously every 24 hours; maropitant 1 mg/kg 
intravenously every 24 hours; ondansetron 0.25 mg/kg intra-
venously every 8 hours; capromorelin 3 mg/kg orally every 24 
hours. After 24 hours of hospitalisation when control of emesis 
was accomplished with antiemetic therapy, a nasogastric tube 
was placed for enteral nutritional support with 50 mL Clini-
Care Canine administered every 6 hours. An indwelling urinary 
catheter was placed to monitor and quantify urine production. 
Prednisone therapy was not instituted due to lack of definitive 
diagnosis, as lymphoma remained on the differential diagnosis 
list and prednisone treatment would make diagnosis challenging. 
Furosemide therapy was not instituted due to the dog’s clinical hydration status in spite of intravenous fluid therapy. Bisphos-
phonate therapy was considered and discussed but not elected 
by the client.
OUTCOME AND FOLLOW-UP
Despite aggressive supportive therapy for 48 hours, the dog’s clinical status continued to decline. A subsequent CBC revealed 
more profound leucocytosis (44.67/µL, RI 6.0–17.0) composed 
of a neutrophilia (39.31/µL, RI 3.0–11.4) and mild left shift 
(893 band neutrophils/µL, RI 0–300) with slight toxic granu-
lation and basophilia; and moderate normocytic, hypochromic, 
non- regenerative anaemia (haematocrit 24.4 per cent, RI 37–55; 
mean corpuscular haemoglobin concentration 30.7 g/dL, RI 
32–36; absolute reticulocyte count 73 500/µL). The repeated 
serum biochemistry profile showed persistent hypercalcemia 
(13.2 mg/dL, RI 9.7–11.3), elevated liver enzyme activities 
(alanine aminotransferase, ALT, 102 IU/L, RI 24–90; alkaline 
phosphatase, ALP, 709 IU/L, RI 20–150) and hyperbilirubinemia 
(total bilirubin 1.75 mg/dL, RI <0.1–0.6), marked azotemia 
(creatinine 5.3 mg/dL, RI 0.5–1.5; blood urea nitrogen 76 mg/
dL, RI 10–30) and hyperphosphatemia (6.3 mg/dL, RI 3.2–6.0). 
Ionised calcium had improved slightly but remained elevated 
(1.61 mmol/L, RI 1.25–1.45).
Exploratory coeliotomy for pancreatic biopsy was discussed 
but not pursued by the client. Due to declining clinical status 
and quality of life, the development of acute kidney injury (AKI) 
and the clinical concern for a diagnosis of neoplasia with a grave 
prognosis, humane euthanasia was elected. Postmortem exam-
ination confirmed the diagnosis of exocrine pancreatic acinar 
adenocarcinoma with local extension to the mesentery, tunica 
muscularis of the adjacent duodenum and into the duodenal 
mucosa (figure 2). Multiple foci of necrosis and haemorrhage 
were noted within the pancreatic adenocarcinoma; no squamous 
differentiation was observed (figure 3). The clinical diagnosis 
of pancreatitis was supported and likely occurred via leakage 
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of digestive enzymes from the neoplastic pancreatic epithe-
lium. Regional metastasis of the pancreatic adenocarcinoma 
was observed to the liver, mesenteric lymph nodes and diffusely 
to the omentum, mesentery, gastrointestinal serosa and surface 
of the urinary bladder. Mild to moderate, multifocal, chronic 
glomerulosclerosis was noted within the kidneys.
Hypercalcemia panel results returned following euthanasia 
and indicated hypercalcemia (ionised calcium 2.04 mmol/L, 
RI 1.24–1.45), PTH at the low end of reference interval (0.70 
pmol/L, RI 0.50–5.80) and markedly elevated PTHrP (7.9 
pmol/L, RI 0.0–1.0 pmol/L). These findings were consistent with 
HM.
DISCUSSION
Exocrine pancreatic adenocarcinoma is an uncommonly 
reported cancer in dogs with an estimated incidence rate of 
17.8 per 100 000 patient years at risk.9 Fewer than 100 cases of 
clinically or pathologically described canine exocrine pancreatic 
adenocarcinoma have been published in the veterinary literature 
since 1963.5 Clinical signs tend to be non- specific and are often 
consistent with those seen in pancreatitis, including lethargy, 
vomiting, diarrhoea, abdominal pain, inappetence and weight 
loss.5 6 Clinicopathology changes also often parallel those seen 
with pancreatitis, including neutrophilia and increased amylase, 
lipase, cPLI and/or cTLI.5 6 If extrahepatic biliary obstruction 
results from the presence of the pancreatic mass, increased 
liver enzyme activities (ALT, ALP) and total bilirubin may be 
observed.5 6 The clinical utility of advanced diagnostic imaging 
(CT, MRI) is not well established for exocrine pancreatic adeno-
carcinoma, as much overlap occurs with pancreatitis.10 While 
ultrasound- guided fine- needle aspirate cytology or biopsy has 
been shown to be helpful in obtaining a diagnosis,6 coeliotomy 
for histopathology is often necessary for definitive diagnosis.5 10 
The case described here had many similar characteristics as those 
previously reported. History, clinical signs, physical examination 
findings and clinicopathology results, and diagnostic imaging 
findings were most consistent with pancreatitis. In this dog, 
however, marked hypercalcemia (with renal values within refer-
ence interval) was noted to have developed within a short period 
of time (total calcium was within reference interval at primary 
care veterinarian 3 days earlier). Marked elevation of PTHrP 
with low PTH confirmed HM.
Hypercalcemia of malignancy associated with exocrine pancre-
atic adenocarcinoma in dogs has not been previously reported 
in the veterinary literature. Lymphoma and AGASAC are the 
neoplasms most commonly associated with HM in dogs.1 3 A 
number of other carcinomas are less frequently reported as 
causes of HM in dogs and have been previously summarised, 
including adrenal, hepatocellular, mammary, pulmonary, squa-
mous cell, transitional cell and so on.2 3 Hypercalcemia of malig-
nancy associated with exocrine pancreatic adenocarcinoma 
is rarely reported in human oncology. When observed, HM 
is typically seen with adenosquamous carcinoma (ASC) of the 
pancreas and is accompanied by elevated levels of PTHrP.4 ASC 
accounts for only 0.38 per cent to 10 per cent of all human 
exocrine pancreatic neoplasms. Diagnostic guidelines require the 
squamous component to comprise at least 30 per cent of the 
pancreatic neoplastic tissue in order to be classified as ASC.4 It 
is believed to be the squamous component of the neoplasm that 
accounts for the PTHrP production.11 In the case reported here, 
no squamous differentiation or component was observed on 
histopathology. While mammary,12 pulmonary13–15 and oesoph-
ageal16 ASC have been reported in dogs, pancreatic origin has 
not. One case of pancreatic ASC in a cat has been published.17
As in this case, canine exocrine pancreatic adenocarcinomas 
are most commonly diagnosed at exploratory coeliotomy or 
postmortem examination.5 10 The clinical prognosis is grave with 
reported survival times ranging from 1 day to several weeks; 
a few cases of hyalinising tubular pancreatic carcinoma have 
been reported with survival over a year.5 18 Diffuse metastasis 
is common in pancreatic exocrine adenocarcinomas at the time 
of diagnosis or postmortem examination.5 6 19 20 Hepatic metas-
tasis is most common, but also seen in regional lymph nodes 
and infiltration on adjacent tissues, as seen in this case. Clinical 
benefit of adjunctive therapies such as chemotherapy or radia-
tion therapy for canine exocrine pancreatic adenocarcinoma has 
not been documented.
The AKI experienced by this dog at the latter stage of the 
disease process likely resulted from the acute pancreatic inflam-
mation associated with the underlying neoplasm and/or from the 
hypercalcemia itself. In this case, histopathology of the pancreas 
included marked inflammation that supported the clinical diag-
nosis of pancreatitis via leakage of digestive enzymes from the 
neoplastic pancreatic epithelium. A recent report identified AKI 
in 17/65 (26 per cent) of dogs with acute pancreatitis and this 
was associated with a poor clinical outcome.21 The pathophys-
iology of renal injury associated with hypercalcemia has been 
previously summarised.2
Figure 2 Pancreatic tumour identiied at postmortem examination.
Figure 3 Histopathology of exocrine pancreatic adenocarcinoma.
Veterinary Record Case Reports
4 Johannes CM, et al. Vet Rec Case Rep 2020;8:e001190. doi:10.1136/vetreccr-2020-001190
Acknowledgements The authors thank Jesse Hostetter, DVM, DACVP, University 
of Georgia, for his contribution in postmortem examination and anatomical 
pathology descriptions.
Contributors CMJ contributed to data collection, analysis of data and writing of 
the manuscript. EREH contributed to the management of the case, data collection 
and writing of the manuscript. MLM contributed to analysis of the data and 
preparation of the manuscript. CBA evaluated the pathology data and contributed to 
the writing of the manuscript.
Funding The authors have not declared a speciic grant for this research from any 
funding agency in the public, commercial or not- for- proit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the 
article.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, an indication of whether changes were made, and the use is non- 
commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iD
Chad M Johannes http:// orcid. org/ 0000- 0003- 1855- 6966
REFERENCES
 1 Mellanby RJ, Craig R, Evans H, et al. Plasma concentrations of parathyroid hormone- 
related protein in dogs with potential disorders of calcium metabolism. Vet Rec 
2006;159:833–8.
 2 Bergman PJ. Paraneoplastic hypercalcemia. Top Companion Anim Med 
2012;27:156–8.
 3 Messinger JS, Windham WR, Ward CR. Ionized hypercalcemia in dogs: a retrospective 
study of 109 cases (1998–2003). J Vet Intern Med 2009;23:514–9.
 4 Borazanci E, Millis SZ, Korn R, et al. Adenosquamous carcinoma of the pancreas: 
molecular characterization of 23 patients along with a literature review. World J 
Gastrointest Oncol 2015;7:132–40.
 5 Aupperle- Lellbach H, Törner K, Staudacher M, et al. Characterization of 22 canine 
pancreatic carcinomas and review of literature. J Comp Pathol 2019;173:71–82.
 6 Bennett PF, Hahn KA, Toal RL, et al. Ultrasonographic and cytopathological diagnosis 
of exocrine pancreatic carcinoma in the dog and cat. J Am Anim Hosp Assoc 
2001;37:466–73.
 7 Holowaychuk MK. Hypocalcemia of critical illness in dogs and cats. Vet Clin North Am 
Small Anim Pract 2013;43:1299–317.
 8 Hellyer PW, Uhrig SR, Robinson NG. Colorado State University Veterinary Medical 
Center canine acute pain scale. Available: http://www. vasg. org/ pdfs/ CSU_ Acute_ 
Pain_ Scale_ Canine. pdf [Accessed 23 Apr 2020].
 9 Priester WA. Data from eleven United States and Canadian colleges of veterinary 
medicine on pancreatic carcinoma in domestic animals. Cancer Res 1974;34:1372–5.
 10 Selmic LE. Exocrine pancreatic cancer. In: Vail DM, Thamm DH, Liptak JM, eds. 
Withrow & MacEwen’s small animal clinical oncology. 6th edn. St Louis: Elsevier, 
c2020: 451.
 11 Trikudanathan G, Dasanu CA. Adenosquamous carcinoma of the pancreas: a distinct 
clinicopathologic entity. South Med J 2010;103:903–10.
 12 Rasotto R, Berlato D, Goldschmidt MH, et al. Prognostic signiicance of canine 
mammary tumor histologic subtypes: an observational cohort study of 229 cases. Vet 
Pathol 2017;54:571–8.
 13 Lee J- H, Lee J- H, Yoon H- Y, et al. Hypertrophic osteopathy associated with pulmonary 
adenosquamous carcinoma in a dog. J Vet Med Sci 2012;74:667–72.
 14 Stewart J, Holloway A, Rasotto R, et al. Characterization of primary pulmonary 
adenosquamous carcinoma- associated pleural effusion. Vet Clin Pathol 
2016;45:179–83.
 15 Sato T, Ito J, Shibuya H, et al. Pulmonary adenosquamous carcinoma in a dog. J Vet 
Med A Physiol Pathol Clin Med 2005;52:510–3.
 16 Okanishi H, Shibuya H, Miyasaka T, et al. Adenosquamous carcinoma of the 
oesophagus in a dog. J Small Anim Pract 2015;56:521–3.
 17 Ogihara K, Madarame H. Pancreatic adenosquamous carcinoma with invasion to the 
spleen in a cat. J Vet Med Sci 2020. doi:10.1292/jvms.20-0244. [Epub ahead of print: 
13 Jul 2020].
 18 Dennis MM, O’Brien TD, Wayne T, et al. Hyalinizing pancreatic adenocarcinoma in six 
dogs. Vet Pathol 2008;45:475–83.
 19 Chang S- C, Liao J- W, Lin Y- C, et al. Pancreatic acinar cell carcinoma with intracranial 
metastasis in a dog. J Vet Med Sci 2007;69:91–3.
 20 Gutierrez- Quintana R, Carrera I, Dobromylskyj M, et al. Pituitary metastasis of 
pancreatic origin in a dog presenting with acute- onset blindness. J Am Anim Hosp 
Assoc 2013;49:403–6.
 21 Gori E, Lippi I, Guidi G, et al. Acute pancreatitis and acute kidney injury in dogs. Vet J 
2019;245:77–81.
Learning points
 ► Exocrine pancreatic adenocarcinoma in dogs can cause 
hypercalcemia of malignancy via production of parathyroid 
hormone–related protein. This is the irst reported case in the 
veterinary literature. This should be a consideration in cases 
of hypercalcemia with pertinent pancreatic clinical signs and/
or changes on diagnostic imaging.
 ► Clinical signs, clinicopathology indings and diagnostic 
imaging show signiicant overlap between pancreatitis 
and exocrine pancreatic adenocarcinoma (due to marked 
pancreatic inlammation associated with the neoplasm).
 ► Fine- needle aspirate cytology of exocrine pancreatic 
adenocarcinoma and/or associated free abdominal luid may 
only yield inlammatory changes; histopathology is often 
necessary for deinitive diagnosis of pancreatic neoplasia.
 ► Exocrine pancreatic adenocarcinoma in dogs is typically 
highly aggressive locally with distant metastasis often 
present at diagnosis. Treatment options are limited and rarely 
reported in the veterinary literature.
 ► Acute pancreatic inlammation and severe hypercalcemia can 
both be associated with acute kidney injury in dogs.
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